An Observational, Retrospective, Postmarketing Safety Study of Trivalent Cell Culture Seasonal Influenza Vaccination (TIVc) (Optaflu) among Adults in Routine UK Care
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 29 Nov 2017 New trial record
- 20 Nov 2017 According to results published in the Pharmacoepidemiology and Drug Safety Journal, this study was stopped when just over half of the planned number of exposures had been identified because the product marketing was discontinued.
- 20 Nov 2017 Results published in the Pharmacoepidemiology and Drug Safety Journal.